Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day Nurtec® ODT for the Preventive Treatment of Migraine

- First clinical trial comparing anti-CGRP migraine preventive medicines INDIANAPOLIS , June 15, 2021 /PRNewswire/ --   To advance the science of migraine treatment and aid the understanding of calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) compared to oral CGRP receptor